⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10344919 | 0.93 | — | — | |
| SCHEMBL10344890 | 0.91 | — | — | |
| SCHEMBL1498091 | 0.85 | — | — | |
| SCHEMBL21069189 | 0.85 | — | — | |
| SCHEMBL5168029 | 0.82 | — | — | |
| SCHEMBL3155618 | 0.79 | — | — | |
| SCHEMBL10993824 | 0.79 | — | — | |
| SCHEMBL11897945 | 0.78 | — | — | |
| SCHEMBL28701219 | 0.76 | — | — | |
| SCHEMBL2517597 | 0.76 | ADRB2 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970146-B1 | ACYLAMINOCYCLOALKYL COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF DOPAMINE D3 RECEPTOR | ABBVIE DEUTSCHLAND (DE) | 2017-11-01 | — | — | EP | disclosed |
| EP-2909201-B1 | ACYLAMINOCYCLOALKYL COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF DOPAMINE D3 RECEPTOR | ABBVIE DEUTSCHLAND (DE) | 2017-02-22 | — | — | EP | disclosed |
| US-9388141-B2 | Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor | ABBVIE INC. (US) | 2016-07-12 | — | — | US | disclosed |
| US-9388148-B2 | Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor | ABBVIE INC. (US) | 2016-07-12 | — | — | US | disclosed |
| US-9376396-B2 | Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor | AbbVie Deutschland GmbH & Co. KG (DE) | 2016-06-28 | — | — | US | disclosed |
| US-20140303176-A1 | ACYLAMINOCYCLOALKYL COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF DOPAMINE D3 RECEPTOR | AbbVie Deutschland GmbH & Co. KG (DE) | 2014-10-09 | — | — | US | disclosed |
| US-20140275104-A1 | ACYLAMINOCYCLOALKYL COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF DOPAMINE D3 RECEPTOR | AbbVie Deutschland GmbH & Co. KG (DE) | 2014-09-18 | — | — | US | disclosed |
| US-20140194437-A1 | ACYLAMINOCYCLOALKYL COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF DOPAMINE D3 RECEPTOR | AbbVie Deutschland GmbH & Co. KG (DE) | 2014-07-10 | — | — | US | disclosed |
| EP-0949231-B1 | FLUORINE-SUBSTITUTED BENZENE DERIVATIVES, LIQUID-CRYSTAL COMPOSITION, AND LIQUID-CRYSTAL DISPLAY ELEMENT | CHISSO CORP (JP) | 2007-05-02 | — | — | EP | disclosed |
| US-6210603-B1 | HIGH VOLTAGE HOLDING RATIO, ALTERED ONLY SLIGHTLY BY CHANGE OF TEMPERATURE, AND LOW THRESHOLD VOLTAGE | CHISSO CORPORATION (JP) | 2001-04-03 | — | — | US | disclosed |
| EP-0949231-A1 | FLUORINE-SUBSTITUTED BENZENE DERIVATIVES, LIQUID-CRYSTAL COMPOSITION, AND LIQUID-CRYSTAL DISPLAY ELEMENT | CHISSO CORPORATION (JP) | 1999-10-13 | — | — | EP | disclosed |
| EP-0113127-B1 | PROCESS FOR PREPARING DIORGANOPOLYSILOXANE CONTAINING FLUOROALKYL GROUPS | Wacker-Chemie GmbH (DE) | 1990-03-07 | — | — | EP | disclosed |
| US-4577040-A | Method for preparing diorganopolysiloxanes containing fluoroalkyl groups | WACKER-CHEMIE GMBH (DE) | 1986-03-18 | — | — | US | disclosed |
| US-4549004-A | ANTIFOAM LUBRICANT | WACKER-CHEMIE GMBH (DE) | 1985-10-22 | — | — | US | disclosed |
| US-4489201-A | Fluoroalkyloxylakyl containing organopolysiloxanes | WACKER-CHEMIE GMBH (DE) | 1984-12-18 | — | — | US | disclosed |
| EP-0113127-A2 | Process for preparing diorganopolysiloxane containing fluoroalkyl groups | Wacker-Chemie GmbH (DE) | 1984-07-11 | — | — | EP | disclosed |